JYJiawen Yin

Jiawen Yin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiawen Yin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Tao Gong

    Neurology Department, Beijing Hospital,National Center for Gerontology;National Clinical Research Center for Gerontology;The Key Laboratory of Geriatrics of NHC;Institute of Geriatric Medicine,Chinese Academy of Medical Sciences, Beijing, China

    3 shared publications
  • Yuhui Chen

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    3 shared publications
  • Lei Xu

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Li Wang

    Department of Neurology, The Affiliated Hospital of Northwest University, Xi’an No.3 Hospital, Xi’an, China

    2 shared publications
  • Qianwen Wang

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Alimu Wufuer

    Department of Neurology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China

    1 shared publication

Latest Publications

  • Relationship between CXCR4 and GNG4 in the Brain and Chronic Stress-Induced Atherosclerosis

    by Qianwen Wang, Lingbing Meng, Ruofan Xu, Jiawen Yin, Deping Liu, Lei Xu, Wei Li, Li Wang, Tao Gong, Yuhui Chen

    Chronic stress (CS) is recognized as a contributing factor to the progression of atherosclerosis (AS), but the molecular mechanisms within the central nerv


  • Development and validation of outcome prediction model for reperfusion therapy in acute ischemic stroke using nomogram and machine learning

    by Qianwen Wang, Jiawen Yin, Lei Xu, Jun Lu, Juan Chen, Yuhui Chen, Alimu Wufuer, Tao Gong

    Objective To develop logistic regression nomogram and machine learning (ML)-based models to predict 3-month unfavorable functional outcome for acute ischemic stroke (AIS) patients undergoing reperfusion therapy. Methods Patients undergoing reperfusion therapy (intravenous thrombolysis and/or endovascular treatment) were prospectively recruited. Unfavorable outcome was defined as 3-month modified Rankin Scale (mRS) score 3–6. The independent risk factors associated with unfavorable outcome were obtained by regression analysis and included in the prediction model. The performance of nomogram was assessed by the area under the curve (AUC), calibration curve, and decision curve analysis (DCA). ML models were compared with nomogram using AUC; the generalizability of all models was ascertained in an external cohort. Results A total of 505 patients were enrolled, with 256 in the model construction, and 249 in the external validation. Five variables were identified as prognostic factors: baseline NIHSS, D-dimer level, random blood glucose (RBG), blood urea nitrogen (BUN), and systolic blood pressure (SBP) before reperfusion. The AUC values of nomogram were 0.865, 0.818, and 0.779 in the training set, test set, and external validation, respectively. The calibration curve and DCA indicated appreciable reliability and good net benefits. The best three ML models were extra trees (ET), CatBoost, and random forest (RF) models; all of them showed favorable discrimination in the training cohort, and confirmed in the test and external sets. Conclusion Baseline NIHSS, D-dimer, RBG, BUN, and SBP before reperfusion were independent predictors for 3-month unfavorable outcome after reperfusion therapy in AIS patients. Both nomogram and ML models showed good discrimination and generalizability.


  • Open Access

    A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies

    by Qianwen Wang, Yuhui Chen, Lingbing Meng, Jiawen Yin, Li Wang, Tao Gong

    Ischemic stroke is a life-threatening condition that also frequently results in long-term disability. Currently, intravenous thrombolysis with tissue plasminogen activator and mechanical thrombectomy is the most popular treatment. However, the narrow time window and related complications limit the treatment benefits. Exosomes have recently emerged as ideal therapeutic candidates for ischemic stroke with the ability to pass through the blood_brain barrier and mediate intercellular communication, in addition, exosomes and their contents can be bioengineered to implement targeted delivery. In the last two decades, exosomes and exosomal noncoding RNAs have been found to be involved in the pathophysiological progression of ischemic stroke, including atherosclerosis, apoptosis, inflammation, oxidative stress, and neurovascular remodeling. In this review, we describe the latest progress regarding the role of exosomal long noncoding RNAs and circular RNAs in the occurrence, progression, and recovery of ischemic stroke. Exploration of exosomal noncoding RNAs and their correlated effects in ischemic stroke may facilitate accurate diagnosis, and they may serve as new therapeutic targets for the disease.